Lunai Bioworks 1-for-8 Split, Shares Fall 12.6%

Lunai Bioworks announced a 1‑for‑8 reverse stock split effective May 22 2026, reducing shares from ~36.3 million to ~4.5 million.
The split aims to lift the share price above Nasdaq’s $1.00 minimum, after a prior 1‑for‑10 split in September 2025.
Shares fell 12.6% on Wednesday, 20 May 2026, and the new CUSIP will be 29350E302 while the ticker remains LNAI.
No fractional shares will be issued; fractions round up, and options, warrants, RSUs and convertible securities will be proportionately adjusted.